Growth is being fueled by stringent regulatory requirements, a global pivot toward animal-free safety assessment, and rising demand from pharmaceutical, cosmetics, and chemical sectors. Regulatory ...
The US Food and Drug Administration (FDA) recently announced a strategic roadmap to phase out animal testing requirements for certain drug products, starting with monoclonal antibodies. This shift ...
Professor of Chemical and Biological Engineering, Biomedical Engineering, and Public Health, Colorado State University A vast number of chemicals are registered for production and use around the world ...
Tampa Free Press on MSN
Rats, rabbits, and reform: EPA revives 2035 deadline to end animal testing
The Environmental Protection Agency is officially putting an expiration date on animal testing again. Administrator Lee Zeldin announced Thursday that the agency is reinstating a hard deadline to ...
The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...
Well before a human receives the first dose of an experimental drug, it’s evaluated in an animal to test for toxicity. Monkeys are often chosen for their genetic similarities to humans, and safe ...
In vitro skin irritation testing has emerged as a critical component in the safety evaluation of chemicals and medical devices, aiming to replace traditional animal-based assays. Central to this ...
Advancing brain microphysiological systems for in vitro neurotoxicity and cognitive function testing
Brain microphysiological systems are reshaping in vitro neurotoxicity testing through functional validation and advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results